WCN26-6378 PLASMA SYMMETRIC DIMETHYLARGININE AS A NOVEL BIOMARKER OF KIDNEY FUNCTION IN LIVING DONORS

However, in the setting of low BKV and moderate CMV burden, this may limit the power to detect clinical significance.This abstract was previously presented at the Malaysian Society of Nephrology (MSN) meeting, and its re-submission is permitted by the original meeting organizers.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.